Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial ; volume:11 ; number:1 ; day:10 ; month:5 ; year:2011 ; pages:1-10 ; date:12.2011
BMC psychiatry ; 11, Heft 1 (10.5.2011), 1-10, 12.2011
- Creator
-
Bossie, Cynthia A.
- Contributor
-
Sliwa, Jennifer K.
Ma, Yi-Wen
Fu, Dong-Jing
Alphs, Larry
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-11-79
- URN
-
urn:nbn:de:1111-2016030432206
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bossie, Cynthia A.
- Sliwa, Jennifer K.
- Ma, Yi-Wen
- Fu, Dong-Jing
- Alphs, Larry
- SpringerLink (Online service)
Other Objects (12)
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Mechanisms of palmitate-induced dysfunction in endothelial cells
β cells keep bad epigenetic memories of palmitate
Development of long-acting ARV’s
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Neural OCR Post-Hoc Correction of Historical Corpora
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
Creation of a long-acting nanoformulated dolutegravir
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Mechanisms of palmitate-induced dysfunction in endothelial cells
β cells keep bad epigenetic memories of palmitate
Development of long-acting ARV’s
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Neural OCR Post-Hoc Correction of Historical Corpora
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
Creation of a long-acting nanoformulated dolutegravir
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Mechanisms of palmitate-induced dysfunction in endothelial cells
β cells keep bad epigenetic memories of palmitate
Development of long-acting ARV’s
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Neural OCR Post-Hoc Correction of Historical Corpora
Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
Creation of a long-acting nanoformulated dolutegravir